RKT logo

Reckitt Benckiser Group plc Stock Price

LSE:RKT Community·UK£30.2b Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 91 Fair Values set on narratives written by author

RKT Share Price Performance

UK£47.67
-3.23 (-6.34%)
UK£62.29
Fair Value
UK£47.67
-3.23 (-6.34%)
23.5% undervalued intrinsic discount
UK£62.29
Fair Value
Price UK£47.67
AnalystConsensusTarget UK£62.29

RKT Community Narratives

·
Fair Value UK£62.29 23.5% undervalued intrinsic discount

Analyst Commentary Highlights Mixed Views as Reckitt Benckiser Updates Guidance and Maintains Valuation

0users have liked this narrative
1users have commented on this narrative
60users have followed this narrative

Trending Discussion

Updated Narratives

RKT logo

RKT: Future Returns Will Hinge On Dividend Growth And Share Buybacks

Fair Value: UK£62.29 23.5% undervalued intrinsic discount
60 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued established dividend payer.

3 Risks
5 Rewards

Reckitt Benckiser Group plc Key Details

UK£14.2b

Revenue

UK£5.6b

Cost of Revenue

UK£8.6b

Gross Profit

UK£5.4b

Other Expenses

UK£3.2b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 29, 2026
5.01
60.78%
22.51%
106.0%
View Full Analysis

About RKT

Founded
1819
Employees
36200
CEO
Kristoffer Licht
WebsiteView website
www.reckitt.com

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Recent RKT News & Updates

Narrative Update May 04

RKT: Future Returns Will Hinge On Dividend Growth And Share Buybacks

Reckitt Benckiser Group's analyst price target has been trimmed by about £1.32 per share, as analysts factor in softer revenue growth and profit margin assumptions alongside a slightly higher future P/E multiple. Analyst Commentary Recent research on Reckitt Benckiser points to a mixed set of views, with some analysts trimming price targets while others are upgrading their stance.
Narrative Update Apr 20

RKT: Future Returns Will Hinge On Dividend And Capital Return Delivery

Analysts have trimmed the fair value estimate for Reckitt Benckiser Group from about £64.42 to £63.61, reflecting slightly softer revenue growth and profit margin assumptions, even as recent research includes both price target cuts and an upgrade on the shares. Analyst Commentary Recent Street research on Reckitt Benckiser Group has mixed signals, with some analysts trimming price targets while another has upgraded the shares, reflecting a balance of confidence in the franchise and caution around execution and earnings quality.
Narrative Update Apr 05

RKT: Future Returns Will Hinge On Emerging Market Mix Execution

Analysts have trimmed the fair value estimate for Reckitt Benckiser Group to £64.42 from £65.63, reflecting recent price target cuts, such as Deutsche Bank's move to £54.60, and a reset of longer term earnings expectations linked to slightly softer revenue growth, a marginally lower profit margin outlook, and a reduced future P/E assumption to 19.99. Analyst Commentary Recent research on Reckitt Benckiser shows a mixed but useful range of views around valuation, execution and growth, with both bullish and bearish analysts adjusting their targets and ratings in response to company specific developments.

Recent updates

No updates